DANATROL Side Effects

6689814-5 | Cytolytic Hepatitis, Diabetes Mellitus
on Apr 14, 2010 Male patient from FRANCE , 64 years of age, was diagnosed with myelofibrosis, splenomegaly and was treated with Danatrol (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, diabetes mellitus. Danatrol dosage: . During the same period patient was treated with VERCYTE (View Vercyte Review and Vercyte Label ). Patient was hospitalized.

5823356-1 | Chest Pain
Patient was taking Danatrol (View Usage). Patient had the following side effects: chest pain (What is chest pain?) on Jul 27, 2007 from FRANCE Additional patient health information: Female patient , 87 years of age, . Danatrol dosage: Unk. Patient was hospitalized.

5412667-X | Demyelination, Weight Increased
Adverse event was reported on Aug 07, 2007 by a Female patient taking Danatrol (View Usage) (Dosage: Unk) was diagnosed with endometriosis (What is endometriosis?) and. Location: BELGIUM , weighting 262.4 lb, After Danatrol was administered, patient had the following side effects: demyelination, weight increased.

5408575-0 | Chest Pain
on Jul 27, 2007 Female patient from FRANCE , 87 years of age, was treated with Danatrol (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?). Danatrol dosage: Unk. Patient was hospitalized.


5390320-9 | Oestradiol Increased, Ovarian Hyperfunction
on Jul 11, 2007 Female patient from SWITZERLAND , 49 years of age, was diagnosed with aplastic anaemia and was treated with Danatrol (View Usage). Patient had the following side effects: oestradiol increased, ovarian hyperfunction. Danatrol dosage: .

4973526-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Blood Creatine Phosphokinase Increased, Muscular Weakness, Pain In Extremity
Patient was taking Danatrol (View Usage). After Danatrol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood creatine phosphokinase increased, muscular weakness, pain in extremity on Feb 28, 2006 from FRANCE Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with thrombocytopenia and. Danatrol dosage: . During the same period patient was treated with CORTANCYL (80 Mg) (View Cortancyl Review and Cortancyl Label ), ZOCOR (Unk) (View Zocor Review and Zocor Label ), EUPANTOL (Unk) (View Eupantol Review and Eupantol Label ), COVERSYL (View Coversyl Review and Coversyl Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ZANIDIP (View Zanidip Review and Zanidip Label ).

4787482-0 | Fluid Retention, Oedema Peripheral, Orthopnoea, Pleural Effusion, Sodium Retention, Weight Increased
Adverse event was reported on Aug 11, 2005 by a Male patient taking Danatrol (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: FRANCE , 57 years of age, weighting 249.1 lb, Patient experienced the following unwanted or unexpected effects: fluid retention, oedema peripheral, orthopnoea, pleural effusion, sodium retention, weight increased. During the same period patient was treated with TENORDATE (View Tenordate Review and Tenordate Label ), INSULIN (View Insulin Review and Insulin Label ), TAHOR (View Tahor Review and Tahor Label ), DIFFU K (View Diffu K Review and Diffu K Label ), TARDYFERON (3 Unit) (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

4750563-1 | Asthenia, Blood Lactate Dehydrogenase Increased, Cardiomegaly, Creatinine Renal Clearance Increased, Fluid Retention, Mitral Valve Incompetence, Oedema Peripheral, Orthopnoea, Pleural Effusion
on Aug 11, 2005 Male patient from FRANCE , 57 years of age, weighting 249.1 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Danatrol (View Usage). Patient had the following side effects: asthenia, blood lactate dehydrogenase increased, cardiomegaly, creatinine renal clearance increased, fluid retention, mitral valve incompetence, oedema peripheral, orthopnoea, pleural effusion. Danatrol dosage: . During the same period patient was treated with TENORDATE (View Tenordate Review and Tenordate Label ), INSULIN (View Insulin Review and Insulin Label ), TAHOR (View Tahor Review and Tahor Label ), LASIX (View Lasix Review and Lasix Label ), DIFFU K (View Diffu K Review and Diffu K Label ), TARDYFERON (3 Unit) (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

4608762-5 | Dermatitis Exfoliative, Toxic Skin Eruption
on Mar 03, 2005 Male patient from , 89 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Danatrol (View Usage). After Danatrol was administered, patient had the following side effects: dermatitis exfoliative, toxic skin eruption. Danatrol dosage: 600 Mg. During the same period patient was treated with POLYKARAYA (12 G) (View Polykaraya Review and Polykaraya Label ), DIFFU K (1800 Mg) (View Diffu K Review and Diffu K Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), DIAFUSOR (View Diafusor Review and Diafusor Label ). Patient was hospitalized.

4605187-3 | Cardiomyopathy, Pulmonary Oedema
Patient was taking Danatrol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?), pulmonary oedema on Mar 01, 2005 from Additional patient health information: Female patient , 66 years of age, . Danatrol dosage: . During the same period patient was treated with DECAPEPTYL (View Decapeptyl Review and Decapeptyl Label ), CONTRAMAL (View Contramal Review and Contramal Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), BIOCARDE (View Biocarde Review and Biocarde Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.